Ragtrader – 6 May 2026 ASX-listed biomaterials company Nanollose (NC6) has secured $1.58 million in new funding since 1 April 2026, following the conversion of options exercisable at $0.025 and $0.05 per option. Read more here
Ragtrader – 6 May 2026 ASX-listed biomaterials company Nanollose (NC6) has secured $1.58 million in new funding since 1 April 2026, following the conversion of options exercisable at $0.025 and $0.05 per option. Read more here
Ragtrader – 6 May 2026 ASX-listed biomaterials company Nanollose (NC6) has secured $1.58 million in new funding since 1 April 2026, following the conversion of options exercisable at $0.025 and $0.05 per option. Read more here
Recent Comments